Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5282294
Max Phase: Preclinical
Molecular Formula: C17H16N2O
Molecular Weight: 264.33
Associated Items:
ID: ALA5282294
Max Phase: Preclinical
Molecular Formula: C17H16N2O
Molecular Weight: 264.33
Associated Items:
Canonical SMILES: Cc1[nH]c2ccccc2c1C1Nc2ccccc2CO1
Standard InChI: InChI=1S/C17H16N2O/c1-11-16(13-7-3-5-9-15(13)18-11)17-19-14-8-4-2-6-12(14)10-20-17/h2-9,17-19H,10H2,1H3
Standard InChI Key: YOUQDMMVNFUQNX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 264.33 | Molecular Weight (Monoisotopic): 264.1263 | AlogP: 4.12 | #Rotatable Bonds: 1 |
Polar Surface Area: 37.05 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.88 | CX Basic pKa: | CX LogP: 3.50 | CX LogD: 3.50 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.69 | Np Likeness Score: -0.20 |
1. Zhu Y, Zhao J, Luo L, Gao Y, Bao H, Li P, Zhang H.. (2021) Research progress of indole compounds with potential antidiabetic activity., 223 [PMID:34192642] [10.1016/j.ejmech.2021.113665] |
Source(1):